4/22
08:59 am
jagx
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society (ONS) Congress in Support of Company's Expanding Focus on Cancer Supportive Care [Yahoo! Finance]
Medium
Report
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society (ONS) Congress in Support of Company's Expanding Focus on Cancer Supportive Care [Yahoo! Finance]
4/22
08:45 am
jagx
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society (ONS) Congress in Support of Company’s Expanding Focus on Cancer Supportive Care
High
Report
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society (ONS) Congress in Support of Company’s Expanding Focus on Cancer Supportive Care
4/22
02:07 am
jagx
Jaguar Health, Inc. (NASDAQ: JAGX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Jaguar Health, Inc. (NASDAQ: JAGX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/18
09:11 am
jagx
Jaguar Health Appoints Biopharmaceutical Industry Veteran to Execute Company's In-licensing Growth Strategy in the Areas of Cancer and GI Supportive Care [Yahoo! Finance]
High
Report
Jaguar Health Appoints Biopharmaceutical Industry Veteran to Execute Company's In-licensing Growth Strategy in the Areas of Cancer and GI Supportive Care [Yahoo! Finance]
4/18
08:30 am
jagx
Jaguar Health Appoints Biopharmaceutical Industry Veteran to Execute Company's In-licensing Growth Strategy in the Areas of Cancer and GI Supportive Care
High
Report
Jaguar Health Appoints Biopharmaceutical Industry Veteran to Execute Company's In-licensing Growth Strategy in the Areas of Cancer and GI Supportive Care
4/16
09:15 am
jagx
Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in its Core Focus Area of Cancer Supportive Care [Yahoo! Finance]
Medium
Report
Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in its Core Focus Area of Cancer Supportive Care [Yahoo! Finance]
4/16
08:30 am
jagx
Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in its Core Focus Area of Cancer Supportive Care
High
Report
Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in its Core Focus Area of Cancer Supportive Care
4/14
02:08 am
jagx
Jaguar Health, Inc. (NASDAQ: JAGX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Jaguar Health, Inc. (NASDAQ: JAGX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/10
11:51 am
jagx
Jaguar Health shareholders approve reverse stock split [Seeking Alpha]
Medium
Report
Jaguar Health shareholders approve reverse stock split [Seeking Alpha]
4/9
04:15 pm
jagx
Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders
High
Report
Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders
4/8
08:49 am
jagx
Jaguar Health Granted Extension Until August 13, 2024, to Regain Compliance with Nasdaq's Bid Price Requirement [Yahoo! Finance]
Medium
Report
Jaguar Health Granted Extension Until August 13, 2024, to Regain Compliance with Nasdaq's Bid Price Requirement [Yahoo! Finance]
4/8
08:30 am
jagx
Jaguar Health Granted Extension Until August 13, 2024, to Regain Compliance with Nasdaq's Bid Price Requirement
Medium
Report
Jaguar Health Granted Extension Until August 13, 2024, to Regain Compliance with Nasdaq's Bid Price Requirement
4/6
02:04 am
jagx
Jaguar Health, Inc. (NASDAQ: JAGX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Jaguar Health, Inc. (NASDAQ: JAGX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/3
07:44 am
jagx
Jaguar Health Full Year 2023 Earnings: US$1.79 loss per share (vs US$36.18 loss in FY 2022) [Yahoo! Finance]
Low
Report
Jaguar Health Full Year 2023 Earnings: US$1.79 loss per share (vs US$36.18 loss in FY 2022) [Yahoo! Finance]
4/2
11:32 am
jagx
Jaguar Health, Inc. (NASDAQ:JAGX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Jaguar Health, Inc. (NASDAQ:JAGX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
4/2
09:29 am
jagx
Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International [Yahoo! Finance]
Low
Report
Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International [Yahoo! Finance]
4/2
08:30 am
jagx
Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International
Low
Report
Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International
4/1
08:19 am
jagx
Jaguar Health Reports 2023 Financial Results [Yahoo! Finance]
High
Report
Jaguar Health Reports 2023 Financial Results [Yahoo! Finance]
4/1
08:00 am
jagx
Jaguar Health Reports 2023 Financial Results
High
Report
Jaguar Health Reports 2023 Financial Results
3/29
02:06 am
jagx
Jaguar Health, Inc. (NASDAQ: JAGX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Jaguar Health, Inc. (NASDAQ: JAGX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/27
08:49 am
jagx
Jaguar Health to Hold Investor Webcast Monday, April 1st at 8:30 AM Eastern Regarding Q4 2023 Financials & Corporate Updates [Yahoo! Finance]
Medium
Report
Jaguar Health to Hold Investor Webcast Monday, April 1st at 8:30 AM Eastern Regarding Q4 2023 Financials & Corporate Updates [Yahoo! Finance]
3/27
08:30 am
jagx
Jaguar Health to Hold Investor Webcast Monday, April 1st at 8:30 AM Eastern Regarding Q4 2023 Financials & Corporate Updates
Medium
Report
Jaguar Health to Hold Investor Webcast Monday, April 1st at 8:30 AM Eastern Regarding Q4 2023 Financials & Corporate Updates
3/21
02:06 am
jagx
Jaguar Health, Inc. (NASDAQ: JAGX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Jaguar Health, Inc. (NASDAQ: JAGX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/20
10:14 am
jagx
JAGX and GNPX among Health Care movers [Seeking Alpha]
Low
Report
JAGX and GNPX among Health Care movers [Seeking Alpha]
3/20
08:30 am
jagx
GEN to Commercialize Jaguar Health's Crofelemer in Turkey and Eight Neighboring Countries and Invest $2 Million in Jaguar Stock at 75% Premium to Market
Medium
Report
GEN to Commercialize Jaguar Health's Crofelemer in Turkey and Eight Neighboring Countries and Invest $2 Million in Jaguar Stock at 75% Premium to Market